Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases

Published:2019-04 Issue:2 Volume:1871 Page:289-312
ISSN:0304-419X
Container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Author:

Cheng Yuan,Ma Xue-lei,Wei Yu-quan,Wei Xia-Wei

Funder

National Major Scientific and Technological Special Project

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Oncology

Reference377 articles.

1. Chemokines: roles in leukocyte development, trafficking, and effector function;Ono;J. Allergy Clin. Immunol.,2003

2. Regulation of the immune response by the interaction of chemokines and proteases;Struyf;Adv. Immunol.,2003

3. Chemokines in tumor development and progression;Mukaida;Exp. Cell Res.,2012

4. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis;Strieter;J. Biol. Chem.,1995

5. Chemokines in tumor-associated angiogenesis;Gerber;Biol. Chem.,2009

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A key regulator of tumor-associated neutrophils: the CXCR2 chemokine receptor;Journal of Molecular Histology;2024-09-13

2. Circadian rhythms and breast cancer: from molecular level to therapeutic advancements;Journal of Cancer Research and Clinical Oncology;2024-09-12

3. Identification of novel targets and mechanisms of wogonin on lung cancer, bladder cancer, and colon cancer;Journal of Future Foods;2024-09

4. The CXCR2 chemokine receptor: A new target for gastric cancer therapy;Cytokine;2024-09

5. Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance;Cancers;2024-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3